Browse > Article
http://dx.doi.org/10.3345/jps.2007.50.12.1173

Juvenile rheumatoid arthritis  

Kim, Dong Soo (Department of Pediatrics, College of Medicine, Yonsei University, Severance Children's Hospital)
Publication Information
Clinical and Experimental Pediatrics / v.50, no.12, 2007 , pp. 1173-1179 More about this Journal
Abstract
The diagnosis of juvenile rheumatoid arthritis (JRA) is based on patient's age at disease onset, symptom duration, gender, and clinical manifestations. JRA is of unknown origin, begins under the age of 16, and persists for a minimum of 6 weeks. JRA is categorized into three principal types, systemic, oligoarticular and polyarticular. Infection, other connective tissue diseases, malignancy, trauma, and immunodeficiency are discussed as differential diagnoses for JRA. Because of joint damage, focusing on early diagnosis and intervention, a vigorous initial therapeutic approach must be taken in patients who have poor prognostic factors. A multidisciplinary team approach is also important for the care of patients with JRA.
Keywords
Juvenile rheumatoid arthritis; Diagnosis; Treatment;
Citations & Related Records
연도 인용수 순위
  • Reference
1 European League Against Rheumatism: EULAR Bulletin No. 4: nomenclature and classification of arthritis in children. Basel (Switzerland), National Zeitung AG, 1977
2 Oen KG, Cheang M. Epidemiology of chronic arthritis in childhood. Semin Arthritis Rheum 1996;26:575-91   DOI   ScienceOn
3 Moore TL, Dorner RW. Separation and characterization of complement-fixing immune complexes in juvenile rheumatoid arthritis patients. Rheumatol Int 1986;6:49-52   DOI
4 Morimoto C, Reinherz EL, Borel Y, et al. Autoantibody to an immunoregulatory inducer population in patients with juvenile rheumatoid arthritis. J Clin Invest 1981;67:753-61   DOI
5 De Benedetti F, Martini A. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol 1998;25:203-7
6 Mangge H, Kenzian H, Gallistl S, et al. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 1995;38:211-20   DOI   ScienceOn
7 Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A. A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol 1999;17:119-122
8 Ahmed S, Ayoub EM. Poststreptococcal reactive arthritis. Pediatr Infect Dis J 2001;20:1081-2   DOI   ScienceOn
9 Rosenberg AM. Treatment of juvenile rheumatoid arthritis: approach to patients who fail standard therapy. J Rheumatol 1996;23:1652-6
10 Keystone EC. The role of tumor necrosis factor antagonism in clinical practice. J Rheumatol 1999;26 Suppl 1:22-8   DOI
11 Tyndall A, Gratwohl A. Bone marrow transplantation in the treatment of autoimmune diseases. Br J Rheumatol 1997; 36:1-3   DOI
12 Levinson JE, Wallace CA. Dismantling the pyramid. J Rheumatol Suppl 1992;33:6-10
13 Stein LD, Roifman CM. Intravenous immunoglobulin therapy. Bull Rheum Dis 1995;44:3-5
14 Cassidy JT, Petty RE. Juvenile rheumatoid arthritis. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. 4th ed. Philadelphia: WB Saunders Co, 2001:218-321
15 Kim DS. Juvenile Rheumatoid Arthritis. In: Clinical Rheumatology Editorial Committee. Clinical Rheumatology. 1st ed. Seoul : Han-kuk Medicine Publishers, 2006:292-313
16 Gong GW, McCrindle BW, Ching JC, Yeung RS. Arthritis presenting during the acute phase of Kawasaki disease. J Pediatr 2006;148:800-5   DOI   ScienceOn
17 Brewer EJ Jr. Pitfalls in the diagnosis of juvenile rheumatoid arthritis. Pediatr Clin North Am 1986;33:1015-32   DOI
18 Brewer EJ Jr., Bass J, Baum J, Cassidy JT, Fink C, Jacobs J, et al. Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of the Arthritis Foundation. Arthritis Rheum 1977;20:195-9
19 Saraux A, Berthelot JM, Chales G, Le Henaff C, Thorel JB, Hoang S, et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001;44:2485-91   DOI   ScienceOn
20 Uziel Y, Pomeranz A, Brik R, et al. Seasonal variation in systemic onset juvenile rheumatoid arthritis in Israel. J Rheumatol 1999;26:1187-9
21 Ayoub EM, Majeed HA. Poststreptococcal reactive arthritis. Curr Opin Rheumatol 2000;12:306-10   DOI   ScienceOn
22 Pasic S, Minic A, Djuric P, et al. Fever of unknown origin in 185 paediatric patients: a single-centre experience. Acta Paediatr 2006;95:463-6   DOI   ScienceOn
23 Howard JF, Sigsbee A, Glass DN. HLA genetics and inherited predisposition to juvenile rheumatoid arthritis. J Rheumatol 1985;12:7-12
24 Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, Talay SR. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest 2003;111: 1905-12   DOI
25 Shin JI, Kim DS, Lee SK, Kim HW. Disease course and prognostic factors of juvenile idiopathic arthritis. J Korean Rheum Asso 2003;10:374-93
26 Cabral DA, Petty RE, Fung M, Malleson PN. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics 1992;89:441-4
27 Duffy CM, Colbert RA, Laxer RM, Schanberg LE, Bowyer SL. Nomenclature and classification in chronic childhood arthritis: time for a change? Arthritis Rheum 2005;52:382-5   DOI   ScienceOn
28 Lohr JA, Hendley JO. Prolonged fever of unknown origin: a record of experiences with 54 childhood patients. Clin Pediatr (Phila) 1977;16:768-73   DOI   ScienceOn
29 Cabral DA, Tucker LB. Malignancies in children who initially present with rheumatic complaints. J Pediatr 1999; 134:53-7   DOI   ScienceOn
30 Ragsdale CG, Petty RE, Cassidy JT, Sullivan DB. The clinical progression of apparent juvenile rheumatoid arthritis to systemic lupus erythematosus. J Rheumatol 1980;7:50-5
31 Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4
32 Woo P. The cytokine network in juvenile chronic arthritis. Ann Med 1997;29:145-7   DOI
33 Kim KN. Treatment of Juvenile Rheumatoid Arthritis. Pediatr Clin Immunol 2007;1:19-32
34 Kim JG, Jung JY, Yoon BY, Hahn YS. Clinical observations on juvenile rheumatoid arthritis (I. systemic type). J Korean Rheum Asso 1994;1:175-82
35 Jacobs JC. Pediatric rheumatology for the practitioner. 2nd ed. New York: Springer-Verlag, 1993:231-359
36 Weiss JE, Ilowite NT. Juvenile idiopathic arthritis. Pediatr Clin North Am 2005;52:413-42   DOI   ScienceOn
37 Allen RC, Dewez P, Stuart L, Gatenby PA, Sturgess A. Antinuclear antibodies using HEp-2 cells in normal children and in children with common infections. J Paediatr Child Health 1991;27:39-42   DOI   ScienceOn
38 Cassidy JT, Levinson JE, Bass JC, Baum J, Brewer EJ, Jr., Fink CW, et al. A study of classification criteria for a diagnosis of juvenile rheumatoid arthritis. Arthritis Rheum 1986;29:274-81   DOI   ScienceOn
39 Petty RE, Cassidy JT, Sullivan DB. Serologic studies in juvenile rheumatoid arthritis: a review. Arthritis and rheumatism 1977 Mar;20(2 Suppl):260-7
40 Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II. Outcome. J Rheumatol 1995;22:308-19
41 Tsokos GC, Inghirami G, Pillemer SR, Mavridis A, Magilavy DB. Immunoregulatory aberrations in patients with polyarticular juvenile rheumatoid arthritis. Clin Immunol Immunopathol 1988;47:62-74   DOI   ScienceOn
42 Avouac J, Gossec L and Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis 2006;65:845-51   DOI   ScienceOn
43 Southwood TR. Psoriatic arthritis. In: Cassidy JT, Petty RE, editors. Textbook of Pediatric Rheumatology. 4th ed. Philadelphia: WB Saunders Co, 2001:345-55
44 Forre O, Dobloug JH, Hoyeraal HM, et al. HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. Arthritis Rheum 1983;26:35-8   DOI   ScienceOn
45 Kim JG. Pathogenesis and Clinical Manifestations of Juvenile Rheumatoid Arthritis. Pediatr Clin Immunol 2007;1: 1-10
46 Jones OY, Spencer CH, Bowyer SL, Dent PB, Gottlieb BS, Rabinovich CE. A multicenter case-control study on predictive factors distinguishing childhood leukemia from juvenile rheumatoid arthritis. Pediatrics 2006;117:840-4   DOI   ScienceOn
47 Ilowite NT. Current treatment of juvenile rheumatoid arthritis. Pediatrics 2002;109:109-15   DOI   ScienceOn
48 Pizzo PA, Lovejoy FH, Jr., Smith DH. Prolonged fever in children: review of 100 cases. Pediatrics 1975;55:468-73
49 De Benedetti F, Massa M, Pignatti P, et al. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9   DOI   ScienceOn
50 Koo ML, Kim DS. The clinical aspects of septic arthritis in children. J Korean Pediatr Soc 1997;40:1737-44